Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen 10:59:55 2024-05-24 am EDT 5-day change 1st Jan Change
928.8 DKK -0.92% Intraday chart for Novo Nordisk A/S +2.82% +33.05%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Wegovy users have less kidney-related health problems, analysis of Novo study finds RE
Health Care Down on Rotation Out of Sector - Health Care Roundup DJ
News Highlights : Top Company News of the Day - Friday at 5 PM ET DJ
US FDA panel votes against use of Novo Nordisk's weekly insulin in type 1 diabetes patients RE
News Highlights : Top Company News of the Day - Friday at 3 PM ET DJ
Top Midday: Intuit, Workday Shares Tumble on Lowered Guidance; Ozempic Reduces Kidney Disease Events, Deaths From Cardiovascular Causes; NHTSA Finds 9 Additional Incidents Tied to Waymo MT
European Equities Mostly Down Friday; German Economy Begins 2024 With 'Positive Sign' MT
NOVO NORDISK : JP Morgan reiterates its Buy rating ZD
Novo Nordisk's Ozempic Reduces Kidney Disease, Death Risk According to Study of Patients With Type 2 Diabetes MT
Ozempic Slows Kidney Disease, Novo Nordisk Study Finds DJ
FMC, Fresenius and Davita rise after Ozempic news DP
Germany's Gerresheimer to acquire Blitz LuxCo for $866 mln RE
Novo Nordisk's Weekly Insulin Flagged for Low Blood Sugar Risk MT
Novo Nordisk Once-Weekly Insulin Icodec Poses Hypoglycemia Risk, FDA Says MT
Novo Nordisk Confirms Fire at Office Building in Denmark; No Injuries Reported MT
US FDA staff flags risk of low blood sugar for Novo Nordisk's weekly insulin RE
Novo Nordisk Faces Second Fire at Danish Headquarters Within a Week MT
Fire Breaks Out in Novo Nordisk Denmark Office Building MT
European shares to hit pause before rising again in 2025 RE
Novo Nordisk Hit by Second Fire in a Week DJ
Novo Nordisk site in Denmark hit by fire RE
Indices: On top of the world Our Logo
Eli Lilly Wins Chinese Approval for Diabetes Drug MT
Australia to ban knock-offs of popular weight-loss drugs Ozempic, Mounjaro RE
Health Care Up as Eli Lilly Hits Record High - Health Care Roundup DJ
Chart Novo Nordisk A/S
More charts
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
928.8 DKK
Average target price
909.2 DKK
Spread / Average Target
-2.11%
Consensus
  1. Stock Market
  2. Equities
  3. NOVO B Stock
  4. News Novo Nordisk A/S
  5. Sector Update: Health Care Stocks Steady Pre-Bell Friday